# Access to Advanced Health Institute

Canonical: https://abierto.us/vendors/access-to-advanced-health-institute-emq1anlatys6

- UEI: EMQ1ANLATYS6
- CAGE: 06UF1
- Location: Seattle, WA
- Awards in window: 3 (11 transactions), -$11,646 obligated, March 5, 2025 to August 31, 2026

## Awarding agencies

- National Institutes of Health: 3 awards, -$11,646

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $0
- 541714 Research and Development in Biotechnology (except Nanobiotechnology): -$11,646

## Competition

- Full and Open Competition: 3 awards

## Largest awards

- 75N93018C00025 (definitive contract): $0, National Institutes of Health Niaid. The Purpose of This Contract Is to Enable Advanced Preclinical Development of an Intranasal Recombinant Amebiasis Vaccine Containing a Liposomal Adjuvant Formulation of Clinical TLR4 and TLR7/8 Ligands.. https://www.usaspending.gov/award/CONT_AWD_75N93018C00025_7529_-NONE-_-NONE-/
- 75N93023C00018 (definitive contract): $0, National Institutes of Health Niaid. BAA Research Area 001: Development of Vaccine Candidates for Biodefense, Antimicrobial Resistant (Amr) Infections and Emerging Infectious Diseases. https://www.usaspending.gov/award/CONT_AWD_75N93023C00018_7529_-NONE-_-NONE-/
- 75N93019C00059 (definitive contract): -$11,646, National Institutes of Health Niaid. Eoi::implementing the Presidents Department of Government Efficiency Cost Efficiency Initiative (March 19, 2025)::EOI Terminate for Convenience - Full.. https://www.usaspending.gov/award/CONT_AWD_75N93019C00059_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/access-to-advanced-health-institute-emq1anlatys6.